Toll-like receptors and their contribution to innate immunity: Focus on TLR4 activation by lipopolysaccharide

Advances in Cell Biology

Volumn 4, Issue 1, 2014, Pages 1-23

  Czerkies, Maciej ^a   Kwiatkowska, Katarzyna ^a   Płytycz, Barbara ^b  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b NONE

Author keywords

Innate immunity; Lipopolysaccharide; Sepsis; Signal transduction; Toll like receptors

Indexed keywords

ADAPTOR PROTEIN; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; CD14 ANTIGEN; I KAPPA B KINASE; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; SCAVENGER RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 2; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ARTICLE; BACTERIAL OUTER MEMBRANE; GENE EXPRESSION; HUMAN; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

EID: 84962122615     PISSN: 0324833X     EISSN: 20802218     Source Type: Journal    
DOI: 10.2478/acb-2014-0001     Document Type: Article

References (87)

1. ANDERSON K V, NÜSSLEIN-VOLHARD C. Information for the dorsal-ventral pattern of the Drosophila embryo is stored as maternal mRNA. Nature 1984;311:223-227.
2. BARANOVA IN, KURLANDER R, BOCHAROV AV, VISHNYAKOVA TG, CHEN Z, REMALEY AT, CSAKO G, PATTERSON AP, EGGERMAN TL. Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signalling. J Immunol 2008;181:7147-7156.
3. BIANCHI ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007;81:1-5.
4. BORTOLUCI KR, MEDZHITOV R. Control of infection by pyroptosis and autophagy: role of TLR and NLR. Cell Mol Life Sci 2010;67:1643-1651.
5. CARTY M, GOODBODY R, SCHRODER M, STACK J, MOYNAGH PN, BOWIE AG. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signalling. Nat Immunol 2006;7:1074-1081.
6. CHIANG C Y, VECKMAN V, LIMMER K, DAVID M. Phospholipase Cγ-2 and intracellular calcium are required for lipopolysaccharide-induced Toll-like receptor 4 (TLR4) endocytosis and interferon regulatory factor 3 (IRF3) activation. J Biol Chem 2012;287:3704-3709.
7. CHOE J, KELKER MS, WILSON IA. Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain. Science 2005;309:581-585.
8. DUERR CU, ZENK SF, CHASSIN C, POTT J, GUTLE D, HENSEL M, HORNEF MW. O-antigen delays lipopolysaccharide recognition and impairs antibacterial host defense in murine intestinal epithelial cells. PLoS Pathog 2009;5:e1000567.
9. DUNZENDORFER S, LEE HK, SOLDAU K, TOBIAS PS. TLR4 is the signalling but not the lipopolysaccharirde uptake receptor. J Immunol 2004;173:1166-1170.
10. ERRIDGE C. Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leukoc Biol 2010;87:989-999.
11. ERRIDGE C, BENNETT-GUERRERO E, POXTON IR. Structure and function of lipopolysaccharides. Microbes Infect 2002;4:837-851.
12. FENTON MJ, GOLENBOCK DT. LPS-binding proteins and receptors. J Leukoc Biol 1998;64:25-32.
13. FITZGERALD KA, MCWHIRTER SM, FAIA KL, ROWE DC, LATZ E, GOLENBOCK DT, COYLE AJ, LIAO SM, MANIATIS T. IKKε and TBK1 are essential components of the IRF3 signalling pathway. Nat Immunol 2003;4:491-496.
14. GAY NJ, GANGLOFF M. Structure and function of Toll receptors and their ligands. Annu Rev Biochem 2007;76:141-165.
15. GAY NJ, GANGLOFF M, O'NEILL LA. What the Myddosome structure tells us about the initiation of innate immunity. Trends Immunol 2011;32:104-109.
16. + (in Polish). Post. Mikrobiol 2011;50:141-154.
17. HASAN UA, DOLLET S, VLACH J. Differential induction of gene promoter constructs by constitutively active human TLRs. Biochem Biophys Res Commun 2004;321:124-131.
18. HASAN U, CHAFFOIS C, GAILLARD C, SAULNIER V, MERCK E, TANCREDI S, GUIET C, BRIERE F, VLACH J, LEBECQUE S, TRINCHIERI G, BATES EE. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol 2005;174:2942-2950.
19. HAWORTH R, PLATT N, KESHAV S, HUGHES D, DARLEY E, SUZUKI H, KURIHARA Y, KODAMA T, GORDON S. The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med 1997;186:1431-1439.
20. HORNG T, BARTON GM, MEDZHITOV IR. TIRAP: an adapter molecule in the Toll signalling pathway. Nat Immunol 2001;2:835-841.
21. HUBER M, KALIS C, KECK S, JIANG Z, GEORGEL P, DU X, SHAMEL L, SOVATH S, MUDD S, BEUTLER B, GALANOS C, FREUDENBERG MA. R-form LPS, the master key to the activation of TLR4/MD-2-positive cells. Eur J Immunol 2006;36:701-711.
22. HUSEBYE H, HALAAS O, STENMARK H, TUNHEIM G, SANDANGER O, BOGEN B, BRECH A, LATZ E, ESPEVIK T. Endocytic pathways regulate Toll-like receptor 4 signalling and link innate and adaptive immunity. EMBO J 2006;25:683-962.
23. HUSEBYE H, AUNE MH, STENVIK J, SAMSTAD E, SKJELDAL F, HALAAS O, NILSEN NJ, STENMARK H, LATZ E, LIEN E, MOLLNES TE, BAKKE O, ESPEVIK T. The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes. Immunity 2010;33:583-596.
24. IWASAKI A, MEDZHITOV R. Regulation of adaptive immunity by the innate immune system. Science 2010;327:291-295.
25. JIANG Z, GEORGEL P, DU X, SHAMEL L, SOVATH S, MUDD S, HUBER M, KALIS S, KECK S, GALANOS C, FREUDENBERG M, BEUTLER B. CD14 is required for MyD88-independent LPS signalling. Nat Immunol 2005;6:565-570.
26. JIN MS, LEE JO. Structures of the toll-like receptor family and its ligand complexes. Immunity 2008;29:182-191.
27. JIN MS, KIM SE, HEO JY, LEE ME, KIM HM, PAIK SG, LEE H, LEE JO. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007;130:1071-1082.
28. JÓZEFOWSKI S. The role of the class A scavenger receptors, SR-A and MARCO, in the immune system. Part 1. The structure of receptors, their ligand binding repertoires and ability to initiate intracellular signalling. Postepy Hig Med Dosw (Online) 2012;6:104-119.
29. KAGAN JC, MEDZHITOV R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signalling. Cell 2006;125:943-955.
30. KAGAN JC, SU T, HORNG T, CHOW A, AKIRA S, MEDZHITOV R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β. Nat Immunol 2008;9:361-368.
31. KANG JY, LEE JO. Structural biology of the Toll-like receptor family. Annu Rev Biochem 2011;80:917-941.
32. KANG JY, NAN X, JIN MS, YOUN SJ, RYU JH, MAH S, HAN SH, LEE H, PAIK SG, LEE JO. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 2009;31:873-884.
33. KAWAI T, AKIRA S. Toll-like receptor and RIG-I-like receptor signalling. Ann N Y Acad Sci 2008;1143:1-20.
34. KAWAI T, AKIRA S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010;11:373-384.
35. KENNEDY MN, MULLEN GE, LEIFER CA, LEE C, MAZZONI A, DILEEPAN KN, SEGAL DM. A complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand for Toll-like receptor 4. J Biol Chem 2004;279:34698-34704.
36. KIM HM, PARK BS, KIM JI, KIM SE, LEE J, OH SC, ENKHBAYAR P, MATSUSHIMA N, LEE H, YOO OJ, LEE JO. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 2007;130:906-917.
37. KIM JI, LEE CJ, JIN MS, LEE CH, PAIK SG, LEE H, LEE JO. Crystal structure of CD14 and its implications for lipopolysaccharide signalling. J Biol Chem 2005;280:11347-11351.
38. KOBE B, KAJAVA AV. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 2001;11:725-732.
39. KUMAR H, KAWAI T, AKIRA S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011;30:16-34.
40. LEELAHAVANICHKUL A, BOCHAROV AV, KURLANDER R, BARANOVA IN, VISHNYAKOVA TG, SOUZA AC, HU X, DOI K, VAISMAN B, AMAR M, SVIRIDOV D, CHEN Z, REMALEY AT, CSAKO G, PATTERSON AP, YUEN PS, STAR RA, EGGERMAN TL. Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice. J Immunol 2012;188:2749-2758.
41. LEMAITRE B, NICOLAS E, MICHAUT L, REICHHART JM, HOFFMANN JA. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996;86:973-983.
42. LEULIER F, LEMAITRE B. Toll-like receptors - taking an evolutionary approach. Nat Rev Genet 2008;9:165-178.
43. LIN SC, LO YC, WU H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 2010;465:885-890.
44. LINGWOOD D, SIMONS K. Lipid rafts as a membrane-organizing principle. Science 2010;327:46-50.
45. LIU L, BOTOS I, WANG Y, LEONARD JN, SHILOACH J, SEGAL DM, DAVIES DR. Structural basis of toll-like receptor 3 signalling with double-stranded RNA. Science 2008;320:379-381.
46. MACLEOD H, WETZLER LM. T cell activation by TLRs: a role for TLRs in the adaptive immune response. Sci STKE 2007;2007(402):e48.
47. MATSUSHIMA N, TANAKA T, ENKHBAYAR P, MIKAMI T, TAGA M, YAMADA K, KUROKI K. Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors. BMC Genomics 2007;8:124.
48. MEDZHITOV R, PRESTON-HURLBURT P, JANEWAY CA JR. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-397.
49. MENG J, PARROCHE P, GOLENBOCK DT, MCKNIGHT CJ. The differential impact of disulfide bonds and N-linked glycosylation on the stability and function of CD14. J Biol Chem 2008;283:3376-33784.
50. MISHRA BB, GUNDRA UM, TEALE JM. Expression and distribution of Toll-like receptors 11-13 in the brain during murine neurocysticercosis. J Neuroinflammation 2008;5:53.
51. MUKHOPADHYAY S, VARIN A, CHEN Y, LIU B, TRYGGVASON K, GORDON S. SRA/MARCO-mediated ligand delivery enhances intracellular TLR and NLR function, but ligand scavenging from cell surface limits TLR4 response to pathogens. Blood 2011;117:1319-1328.
52. NAGAI Y AKASHI S, NAGAFUKU M, OGATA M, IWAKURA Y, AKIRA S, KITAMURA T, KOSUGI A, KIMOTO M, MIYAKE K. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 2002;3:667-672.
53. NUNEZ MIGUEL R, WONG J, WESTOLL JF, BROOKS HJ, O'NEILL LA, GAY NJ, BRYANT CE, MONIE TP. A d imer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins. PLoS One 2007;2:e788.
54. NYMAN T, STENMARK P, FLODIN S, JOHANSSON I, HAMMARSTROM M, NORDLUND P. The crystal structure of the human Toll-like receptor 10 cytoplasmic domain reveals a putative signalling dimer. J Biol Chem 2008;283:11861-11865.
55. OHTO U, FUKASE K, MIYAKE K, SATOW Y. Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science 2007;316:1632-1633.
56. PANTER G, JERALA R. The ectodomain of the Toll-like receptor 4 prevents constitutive receptor activation. J Biol Chem 2011;286:23334-13344.
57. PARK BS, SONG DH, KIM HM, CHOI BS, LEE H, LEE JO. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 2009;458:1191-1195.
58. PIFER R, BENSON A, STURGE CR, YAROVINSKY F. UNC93B1 is essent ial for TLR11 act ivat ion and IL-12-dependent host resistance to Toxoplasma gondii. J Biol Chem 2011;286:3307-3314.
59. POLTORAK A, HE X, SMIRNOVA I, LIU MY, VAN HUFFEL C, DU X, BIRDWELL D, ALEJOS E, SILVA M, GALA-NOS C, FREUDENBERG M, RICCIARDI CASTAGNOLI P, LAYTON B, BEUTLER B. Defective LPS signalling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-2088.
60. RAETZ CR, WHITFIELD C. Lipopolysaccharide endotoxins. Annu Rev Biochem 2002;71:635-700.
61. RESMAN N, VASL J, OBLAK A, PRISTOVSEK P, GIOANNINI TL, WEISS JP, JERALA R. Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin. J Biol Chem 2009;284:15052-15060.
62. RIETSCHEL ET, KIRIKAE T, SCHADE FU, MAMAT U, SCHMIDT G, LOPPNOW H, ULMER AJ, ZAHRINGER U, SEYDEL U, DI PADOVA F, SCHREIER M, BRADE H. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994;8:217-225.
63. RITTIG MG, KAUFMANN A, ROBINS A, SHAW B, SPRENGER H, GEMSA D, FOULONGNE V, ROUOT B, DORNAND J. Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes. J Leukoc Biol 2003;74:1045-1055.
64. ROLLS A, SHECHTER R, LONDON A, ZIV Y, RONEN A, LEVY R, SCHWARTZ M. Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol 2007;9:1081-1088.
65. SALOMAO R, BRUNIALTI MK, RAPOZO MM, BAGGIO-ZAPPIA GL, GALANOS C, FREUDENBERG M. Bacterial sensing, cell signalling, and modulation of the immune response during sepsis. Shock 2012;38:227-242.
66. SATOH T, KATO H, KUMAGAI Y, YONEYAMA M, SATO S, MATSUSHITA K, TSUJIMURA T, FUJITA T, AKIRA S, TAKEUCHI O. LGP2 is a positive regulator of RIG-I and MDA5-mediated antiviral responses. Proc Natl Acad Sci USA 2010. 107:1512-517.
67. SCHNARE M, BARTON GM, HOLT AC, TAKEDA K, AKIRA S, MEDZHITOV R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001;2:947-950.
68. SHIBATA T, MOTOI Y, TANIMURA N, YAMAKAWA N, AKASHI-TAKAMURA S, MIYAKE K. Intracellular TLR4/MD-2 in macrophages senses Gram-negative bacteria and induces a unique set of LPS-dependent genes. Int Immunol 2011;23:503-510.
69. SILHAVY TJ, KAHNE D, WALKER S. The bacterial cell envelope. Cold Spring Harb Perspect Biol 2010;2:a000414.
70. SUN J, DUFFY KE, RANJITH-KUMAR CT, XIONG J, LAMB RJ, SANTOS J, MASARAPU H, CUNNINGHAM M, HOLZENBURG A, SARISKY RT, MBOW ML, KAO C. Structural and functional analyses of the human Toll-like receptor 3. Role of glycosylation. J Biol Chem 2006;281:11144-11151.
71. TRIANTAFILOU M, MORATH S, MACKIE A, HARTUNG K, TRIANTAFILOU K. Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane. J Cell Sci 2004;117:4007-4014.
72. TRIANTAFILOU M, LEPPER PM, BRIAULT CD, AHMED MA, DMOCHOWSKI JM, SCHUMANN C, TRIANTAFILOU K. Chemokine receptor 4 (CXCR4) is part of the lipopolysaccharide "sensing apparatus". Eur J Immunol 2008;38:192-203.
73. TRIANTAFILOU M, LEPPER PM, OLDEN R, DIAS IS, TRIANTAFILOU K. Location, location, location: Is membrane partitioning everything when it comes to innate immune activation? Mediators Inflamm 2011;2011:186093.
74. WANG Y, CHEN T, HAN C, HE D, LIU H, AN H, CAI Z, CAO X. Lysosome-associated small Rab GTPase Rab7b negatively regulates TLR4 signalling in macrophages by promoting lysosomal degradation of TLR4. Blood 2007;110:962-971.
75. WANG D, LOU J, OUYANG C, CHEN W, LIU Y, LIU X, CAO X, WANG J, LU L. Ras-related protein Rab10 facilitates TLR4 signalling by promoting replenishment of TLR4 onto the plasma membrane. Proc Natl Acad Sci USA 2010;107:13806-13811.
76. WANG Y, YANG Y, LIU X, WANG N, CAO H, LU Y, ZHOU H, ZHENG J. Inhibition of clathrin/dynamin-dependent internalization interferes with LPS-mediated TRAM-TRIF-dependent signalling pathway. Cell Immunol 2012;274:121-129.
77. WATTERS TM, KENNY EF, O'NEILL LA. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins. Immunol Cell Biol 2007;85:411-419.
78. WEBER AN, MORSE MA, GAY NJ. Four N-linked glycosylation sites in humantoll-like receptor 2 coooperate to direct efficient biosynthesis and secretion. J Biol Chem 2004;279:34589-34594.
79. WEISS J. Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gram-negative bacteria. Biochem Soc Trans 2003;31:785-790.
80. WONG SW, KWON MJ, CHOI AM, KIM HP, NAKAHIRA K, HWANG DH. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem 2009;284:27384-27392.
81. XU Y, TAO X, SHEN B, HORNG T, MEDZHITOV R, MANLEY JL, TONG L. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature, 2000;408:111-115.
82. YAMAMOTO M, SATO S, HEMMI H, UEMATSU S, HOSHINO K, KAISHO T, TAKEUCHI O, TAKEDA K, AKIRA S. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signalling pathway. Nat Immunol 2003;4:144-1150.
83. YAMAMOTO M, OKAMOTO T, TAKEDA K, SATO S, SANJO H, UEMATSU S, SAITOH T, YAMAMOTO N, SAKURAI H, ISHII KJ, YAMAOKA S, KAWAI T, MATSUURA Y, TAKEUCHI O, AKIRA S. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signalling. Nat Immunol 2006;7:962-970.
84. YANG H, HREGGVIDSDOTTIR HS, PALMBLAD K, WANG H, OCHANI M, LI J, LU B, CHAVAN S, ROSAS-BALLINA M, AL-ABED Y, AKIRA S, BIERHAUS A, ERLADSSON-HARRIS H, ABDERSSON U, TRACEY KJ. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci USA 2010;107:11942-11947.
85. ZANONI I, OSTUNI R, MAREK LR, BARRESI S, BARBALAT R, BARTON GM, GRANUCCI F, KAGAN JC. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 2011;147:868-880.
86. ZHANG D, ZHANG G, HAYDEN MS, GREENBLATT MB, BUSSEY C, FLAVELL RA, GHOSH IS. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004;303:1522-1526.
87. ZHU X, OWEN JS, WILSON MD, LI H, GRIFFITHS GL, THOMAS MJ, HILTBOLD EM, FESSLER MB, PARKS JS. Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J Lipid Res 2010;51:3196-3206.